Key terms

About SSNC

SS&C Technologies Holdings, Inc. engages in the development and provision of software solutions to the financial services and healthcare industries. It operates through the following geographical segments: United States, Europe, Middle East and Africa, Asia Pacific and Japan, Canada, and the Americas, excluding the United States and Canada. Its products include advent genesis, antares, asset allocators, AWD, axys, BANC mall, BRIX, DST vision, evare, lightning, and moxy. The company was founded by William Charles Stone in March 1986 and is headquartered in Windsor, CT.

Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
     
52-week range
     
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date

Key terms

Smart score

Latest SSNC news

Yesterday 6:45am ET SS&C Technologies Holdings: Outperforming with Raised FY24 Guidance and Strong Q1 Results Yesterday 6:37am ET RBC Capital Sticks to Their Buy Rating for SS&C Technologies Holdings (SSNC) Yesterday 6:10am ET Analysts Have Conflicting Sentiments on These Technology Companies: SS&C Technologies Holdings (SSNC), KLA (KLAC) and Fair Isaac (FICO) Apr 25 10:59pm ET Analysts Offer Insights on Technology Companies: Check Point (CHKP) and SS&C Technologies Holdings (SSNC) Apr 25 4:12pm ET SS&C sees FY24 adjusted EPS $4.93-$5.17, consensus $5.08 Apr 25 4:11pm ET SS&C sees Q2 adjusted EPS $1.16-$1.22, consensus $1.21 Apr 25 4:10pm ET SS&C reports Q1 adjusted EPS $1.28, consensus $1.21 Apr 16 8:25am ET D.A. Davidson Reaffirms Their Buy Rating on SS&C Technologies Holdings (SSNC) Feb 14 9:28am ET SS&C price target raised to $72 from $65 at RBC Capital Feb 14 8:09am ET SS&C price target raised to $60 from $55 at Truist Feb 14 7:35am ET SS&C price target raised to $70 from $62 at Needham Feb 13 4:11pm ET SS&C sees Q1 adjusted EPS $1.19-$1.25, consensus $1.23 Feb 13 4:11pm ET SS&C sees FY24 adjusted EPS $4.85-$5.15, consensus $5.14 Feb 13 4:10pm ET SS&C reports Q4 adjusted EPS $1.26, consensus $1.24 Jan 30 6:50am ET SS&C price target raised to $76 from $71 at JPMorgan Jan 30 6:13am ET Enfusion downgraded to Underweight on client risks at JPMorgan

No recent press releases are available for SSNC

SSNC Financials

1-year income & revenue

Key terms

SSNC Forecasts

analyst rating

  • buy
  • hold
  • sell

We're sorry, but this
information is
temporarily unavailable.

1-year stock price forecast

SSNC Competitors

$ Market cap P/E ratio $ Price 1d change 52-week range

Key terms